Search - tctmd.com

Displaying 41 - 60 of 302

Sort: Relevancy | Date

Presentation TCT 2022

TCT 768: TAVR for the Patient with Sub-Aortic Valve Band and VSD

Presenter: Hirotsugu Mitsuhashi

September 19, 2022

Presentation TCT 2022

TCT 366: Comparison of Hemodynamic Performance of Transcatheter Aortic Valve Replacement with Supra-Annular Self-Expanding versus Balloon-Expandable Valves Assessed by Exercise Cardiovascular Magnetic Resonance

Presenter: Luis Augusto Palma Dallan

September 19, 2022

Presentation TCT 2022

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

Presenter: Keith Allen

September 19, 2022

Presentation TCT 2022

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Khawaja Akhtar

September 19, 2022

Presentation TCT 2022

TCT 801: Transcatheter Aortic Valve Implantation for a Degenerated Transcatheter Aortic Valve in a Surgical Bioprosthetic Valve

Presenter: Riyad Kherallah

September 19, 2022

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

$TCT 708: Balloon ring fracture and transcatheter aortic valve-in-valve implantation into a failed Direct Flow Medical prosthesis: in-vitro benchmark tests and in-vivo treatment$

Presentation TCT 2022

TCT 708: Balloon ring fracture and transcatheter aortic valve-in-valve implantation into a failed Direct Flow Medical prosthesis: in-vitro benchmark tests and in-vivo treatment

Presenter: Axel Unbehaun

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 679: Aortic root stenless prosthesis with severe regurgitation, valve in valve with a novel device.

Presenter: Manuel Duarte

September 19, 2022

Presentation TCT 2022

TCT 422: Association Between Site Safety Outcomes of Aortic Valve Replacement and Edge-to-Edge Repair in The United States

Presenter: Alejandra Chavez Ponce

September 19, 2022

Presentation TCT 2022

Valve Function Insights from Bench Testing

Presenter: Janarthanan Sathananthan

September 18, 2022

TAVR of Yesterday is not the TAVR of the Future

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Presenter: Robert Hawkins

September 18, 2022

Presentation TCT 2022

Results and benefits of aortic intervention in the US by age.

Presenter: Megan Coylewright

September 18, 2022

Presentation TCT 2022

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Presenter: Santiago Garcia

September 18, 2022

Presentation TCT 2022

Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry

Presenter: Suzanne Arnold

September 18, 2022

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

Presentation TCT 2022

Planning for TAV-in-TAV: Technical Considerations

Presenter: Janarthanan Sathananthan

September 18, 2022

Advertisement

TCT 768: TAVR for the Patient with Sub-Aortic Valve Band and VSD

TCT 366: Comparison of Hemodynamic Performance of Transcatheter Aortic Valve Replacement with Supra-Annular Self-Expanding versus Balloon-Expandable Valves Assessed by Exercise Cardiovascular Magnetic Resonance

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

TCT 801: Transcatheter Aortic Valve Implantation for a Degenerated Transcatheter Aortic Valve in a Surgical Bioprosthetic Valve

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

TCT 708: Balloon ring fracture and transcatheter aortic valve-in-valve implantation into a failed Direct Flow Medical prosthesis: in-vitro benchmark tests and in-vivo treatment

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 679: Aortic root stenless prosthesis with severe regurgitation, valve in valve with a novel device.

TCT 422: Association Between Site Safety Outcomes of Aortic Valve Replacement and Edge-to-Edge Repair in The United States

Valve Function Insights from Bench Testing

TAVR of Yesterday is not the TAVR fo the Future

TAVR of Yesterday is not the TAVR fo the Future

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Results and benefits of aortic intervention in the US by age.

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Planning for TAV-in-TAV: Technical Considerations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content